EUVIMEDEUVIMED entdecken
Crossref

Aptamer‐Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy

Ruirui Zhao, Yunfeng Bai, Yujing Guo, Feng Feng iD, Shaomin Shuang

Macromolecular Bioscience · 2024-04 · 24 (4)

DOI: 10.1002/mabi.202300420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 20.12.2023. Verfasst von Ruirui Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Institute of Environmental Science, Shanxi University, Taiyuan, 030006, China. Hauptthemen laut MEDLINE: Nanostructures, Neoplasms, Aptamers, Nucleotide. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Cultivate Scientific Research Excellence Programs of Higher Education Institutions in Shanxi, Shanxi Scholarship Council of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Improving the selective delivery and uptake efficiency of chemotherapeutic drugs remains a challenge for cancer‐targeted therapy. In this work, a DNA tetrahedron is constructed as a targeted drug delivery system for efficient delivery of doxorubicin (Dox) into cancer cells. The DNA tetrahedron is composed of a tetrahedral DNA nanostructure (TDN) with two strands of AS1411 aptamer as recognition elements which can target the nucleolin protein on the cell membrane of cancer cells. The prepared DNA tetrahedron has a high drug‐loading capacity and demonstrates pH‐responsive Dox release properties. This enables efficient delivery of Dox into targeted cancer cells while reducing side effects on nontarget cells. The proposed drug delivery system exhibits significant therapeutic efficacy in vitro compared to free Dox. Accordingly, this work provides a good paradigm for developing a targeted drug delivery system for cancer therapy based on DNA tetrahedrons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanostructuresNeoplasmsAptamers, NucleotideHumansDrug CarriersDrug Delivery SystemsDNADoxorubicinCell Line, Tumor

Stichwörter der Autor:innen

AS1411 aptamerDNA tetrahedrontargeted drug deliverytargeted therapytherapeutic efficacy

Substanzen

Drug CarriersDNADoxorubicinAptamers, Nucleotide

Autor:innen und Institutionen

  • College of Chemistry and Chemical Engineering, Institute of Environmental Science, Shanxi University, Taiyuan, 030006, China.
  • School of Chemistry and Chemical Engineering, Shanxi Provincial Key Laboratory of Chemical Biosensing, Shanxi Datong University, Datong, 037009, China.

ORCID-Profile: Feng Feng

Förderung

  • National Natural Science Foundation of China
  • Cultivate Scientific Research Excellence Programs of Higher Education Institutions in Shanxi
  • Shanxi Scholarship Council of China
  • Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi
  • Fundamental Research Program of Shanxi Province
  • Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province

Zitieren

APA

Zhao, R., Bai, Y., Guo, Y., Feng, F., & Shuang, S. (2024). Aptamer‐Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy. Macromolecular Bioscience, 24(4). https://doi.org/10.1002/mabi.202300420

Vancouver

Zhao R, Bai Y, Guo Y, Feng F, Shuang S. Aptamer‐Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy. Macromolecular Bioscience. 2024;24(4). doi:10.1002/mabi.202300420

BibTeX
@article{Zhao2024,
  author = {Zhao, Ruirui and Bai, Yunfeng and Guo, Yujing and Feng, Feng and Shuang, Shaomin},
  title = {Aptamer‐Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy},
  journal = {Macromolecular Bioscience},
  year = {2024},
  volume = {24},
  number = {4},
  doi = {10.1002/mabi.202300420}
}
Kostenlos starten →